Identifying and tracking patients who are likely to be readmitted, gamification strategies for employer wellness programs and interoperability are a few of the technologies from startup and growth stage companies pitching at the IMPACT conference scheduled for October 22-23. Some DreamIT Health accelerator graduates are among them. There will also be biotechnology companies such as Galderma, which got FDA approval in August for its topical treatment for the facial redness that comes with the condition, rosacea.
Here’s a list of the healthcare and life science companies presenting, some of which are on Twitter.
Health IT
CardioReady (@CardioReady) is all about automated external defibrillators and helps customers evaluate, buy, install, track, and maintain them.
Healthper (@HealthPer) works with employer wellness plans using a mix of gamification and incentives to change behavior and improve engagement in users’ health.
Moberg Research is a medical device producer focused on neurological patient monitoring.
RightCare Solutions (@TeamRightCare) helps hospitals reduce readmissions using a discharge decision support system.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
United Preference (@UTDPreference) works with an employer wellness plans to improve the use of pre-paid cards but limits how they can be used, such as paying for over-the-counter medications and supplements from drugstores, healthy foods from supermarkets and gym memberships.
Nuvon (@NuvonVega) provides real-time synchronization of patient-centric medical device data to keep patient records up to date. It also has a charting system to validate data and identify trends.
Early Stage
AirCare Labs helps hospitals prevent readmissions and improve patient outcomes through tele-nursing. It was part of the inaugural class at DreamIt Health.
Coriell Life Sciences wants to make it easier for physicians to order, store and interpret genome sequence data. It transmits queries from physicians to genomic-sequencing interpreters. It also provides cloud-based storage for each patient’s genomic sequence. Through the ecosystem it is setting up, it is facilitating the interaction between physicians, researchers and the interpreters of that data. Its a spinoff from the Coriell Institute.
Lucidity Health (@LucidityHealth) seeks to improve price transparency within hospitals and is also a graduate of the DreamIt Health accelerator.
Osmosis (@OsmoseIT) has a medical school study app to reinforce learning and retain information beyond the next exam. It was part of the DreamIt Health inaugural class this year.
PHmHealth is combating fraud in the home health care market. Its platform uses patient data to create an auditable trail of visit activity, helping home health agencies create efficiencies, reducing payers’ and patients’ risk of improper billing or fraud.
Seratis is a healthcare communication platform set up as an alternative to pagers. The founders hate pagers. A lot.
SpeSo Health (@SpeSoHeath) developed an app to help connect patients with a global network of rare disease experts.
Healthcare
Aclaris Therapeutics was formed last year and is developing topical dermatology therapeutics.
CytoVas has developed a blood-based diagnostic test that predicts a person’s risk of heart attack and stroke. It has partnered with Beckton Dickinson and has been part of the UpStart technology transfer program at University of Pennsylvania and the American Heart Association’s science and technology accelerator.
Edge Therapeutics Its pipeline of drugs targets delayed complications that follow brain hemorrhages.
Genocea Biosciences has used T cell antigens to develop vaccines to reduce the severity and frequency of clinical outbreaks associated with herpes simplex virus type 2. It also has a preclinical vaccine to prevent infections associated with streptococcus pneumonia.
Hybridyne Imaging Technologies has developed imaging devices to combat cancer. It has a compact cancer imaging device to localize the uptake of radiation in tissue in assisting with diagnosis at an early stage and with radiopharmaceutical-guided surgery.
Merganser Biotech is developing treatments for beta thalassemia and other diseases associated with iron overload
Micro Interventional Devices a cardiovascular medical device company developing technology to assist with percutaneous and minimally invasive structural heart repair procedures.
Soft Tissue Regeneration is a medical device company developing technology to regenerate soft tissue. It’s designed a bioresorbable scaffold for the reconstruction of the anterior cruciate ligament for the knee, the ACL.
TB Biosciences has sought to update the sputum test for detecting tuberculosis with a more accurate test that uses proteins to detect active TB antibodies in the blood.
Thubrikar Aortic Valve (LinkedIn page) has produced a new generation of Transcathter Aortic Valve (to address the limitations of existing TAVs and improve treatment for Severe Aortic Stenosis patients.
